Solid Biosciences Inc.
SLDBBiotechnology
$6.39−1.39%As of Oct 29vs prior close
- Market cap
- $685.2M
- P/E (TTM)
- –
- From 52W high
- −42.69%
- EPS (LTM)
- -$1.88
- Revenue (YE22)
- $8.1M
- Dividend yield
- 0.00%
Nomior Score
44
Steady ProfileBottom 36% of the scored universe
Growth—
Quality44
Value36
Momentum66
Resilience39
Growth
$8.1Mrevenue, YE22
YE16 $0YE22 $8.1M
Connections
Revenue to profitYE22
The operating loss was 1315% of revenue, wider by 785 pts on a year.
Who owns it
2funds